E22 General Considerations for Patient Preference Studies; International Council for Harmonisation; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled "E22 General Considerations for Patient Preference Studies." The draft...
Sign up to read the full analysisDocument type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-02-06.
Why this matters to food and beverage teams
This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
The practical question is whether this changes operational compliance requirements and enforcement posture. If it does, pull the source document and decide whether the item needs action now, monitoring, or no response.
Track this document and its deadlines
Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.
Sign Up Free